Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000295411 is a noncoding, sense-strand intronic transcript embedded within the TMEM132B gene locus. It is identified and annotated by genomic sequencing projects but has no characterized function, disease role, molecular classification (beyond RNA), or clinical significance. Its proximity to TMEM132B—a protein-coding gene associated with deafness—does not itself confer any established properties, activity, or biological relevance, pending experimental validation. TMEM132B (Transmembrane Protein 132B), the nearest protein-coding gene, is located approximately 17,547 base pairs from ENSG00000295411. However, unless new data emerge, ENSG00000295411 should not be used as a molecular target in structured databases and scientific queries.
None, as no drugs target this transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, sense intronic to TMEM132B (ENSG00000295411).